Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
B-Pharm is a prominent Russian pharmaceutical company dedicated to the development, manufacturing, and distribution of high-quality medicinal products for the treatment of socially significant and rare diseases. The company maintains a robust portfolio focused on oncology, hematology, infectious diseases, and nephrology, providing both innovative therapies and high-tech biosimilars. B-Pharm operates a state-of-the-art manufacturing facility in the Dubna Special Economic Zone, which is designed in compliance with international GMP standards. Through strategic partnerships with global pharmaceutical leaders, B-Pharm facilitates the localization of advanced medical technologies within the Russian Federation. The company is a significant participant in state procurement programs, ensuring the availability of essential medicines across the country.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on B-Pharm.